- Autoimmune disease diagnostics are essential for the early detection and management of conditions where the immune system mistakenly attacks the body’s own tissues. These tests are critical for diseases such as rheumatoid arthritis, lupus, and type 1 diabetes, enabling timely interventions that can significantly improve patient outcomes.
- The demand for these diagnostics is significantly driven by the rising prevalence of autoimmune diseases, technological advancements in testing methods, and increasing awareness about the importance of early detection
- North America is expected to dominate the autoimmune disease diagnostics market, with a projected market share of 39.6%, driven by advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and the strong presence of key market players
- Asia-Pacific is expected to be the fastest growing region in the autoimmune disease diagnostics market, with a projected CAGR of 9.7%, driven by rapid expansion in healthcare infrastructure, increasing awareness about autoimmune disorders, and rising diagnostic volumes
- Rheumatoid arthritis is expected to dominate the market, with 57.8% of the share, due to its high prevalence and chronic nature. As a leading autoimmune disorder, early and accurate diagnosis is critical for effective disease management and prevention of joint damage, driving the demand for advanced diagnostic solutions
